We are focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need.

Our technology

The unique potential of Radiopharmaceuticals in treating oncological diseases.

Learn more

Our pipeline

The unique potential of being First to Market or Best in Class.

Learn more

Our team

We have a unique commitment to improve patients’ hope in fighting cancer.

Learn more

Information for investors

Stock price, Company governance & updates from our multiple development programs.

Learn more

Latest news

ASX Releases

RAD Invited to Participate in Jefferies Radiopharma Innovation Summit

March 28, 2023

Read moreRead more

ASX Releases

RAD Receives $1.56M R&D Tax Incentive

March 28, 2023

Read moreRead more

ASX Releases

RAD and GenesisCare Partner to Develop Novel Radiopharmaceuticals in Australia

March 27, 2023

Read moreRead more